Bioabsorbable Therapeutics

**Bioabsorbable Therapeutics**

Bioabsorbable Therapeutics specializes in the creation and distribution of medical devices for coronary and peripheral vascular disease treatment. Their product lineup includes the Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent, and the Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company develops bioabsorbable coatings and stents using anti-inflammatory polymers. Established in 2004, Bioabsorbable Therapeutics operates from its headquarters in Menlo Park, California.

**Investment**

The company received a $359.71K debt financing investment on 13 March 2009.

**Industry**

Key industries: Biotechnology, Health Care, Medical Devices.

This startup has a niche focus on bioabsorbable stent systems for cardiovascular treatments, positioning itself in the rapidly advancing medical devices industry. With a proven track record of innovation, Bioabsorbable Therapeutics has garnered investor interest, with a notable $359.71K debt financing injection in 2009. The company's location in Menlo Park, California provides access to the rich technological and investment ecosystem in the region.